Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Baiyunshan: Subsidiary's Xuhan Ting Granules Approved for New Clinical Trial in Children with Recurrent Respiratory Tract Infections
Recently, Baiyunshan announced that its subsidiary, Guangzhou Baiyunshan Qixing Pharmaceutical Co., Ltd., has received the clinical trial approval notice for the additional indications of Xuhanting Granules.
Xuhanting Granules have the effects of benefiting qi and nourishing yin, stabilizing the exterior, and stopping sweating. They are used for spontaneous sweating, night sweats, and children’s night sweats caused by deficiency of qi and yin. This product is an already marketed traditional Chinese medicine compound preparation. The current application is for clinical trials to add use in children with recurrent respiratory infections.
As of the date of this announcement, Qixing Pharmaceutical has invested approximately 20.52 million yuan in research and development for Xuhanting Granules. In 2024, Qixing Pharmaceutical’s sales of Xuhanting Granules are expected to reach 49.09 million yuan.
(Baiyunshan Announcement)
(Edited by: Yang Yan, Lin Chen)
Keywords: Medical